Tourbillon Capital Partners, L.P. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 153 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tourbillon Capital Partners, L.P. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2018$13,071,000
-64.8%
285,091
-54.5%
1.41%
-1.9%
Q2 2018$37,084,000
+29.1%
626,950
+48.6%
1.43%
+25.9%
Q1 2018$28,715,000
+228.5%
421,966
+322.0%
1.14%
+578.0%
Q2 2017$8,740,000
-48.5%
100,000
-78.1%
0.17%
-61.6%
Q1 2017$16,967,000
+23.2%
456,097
+1.7%
0.44%
+64.9%
Q4 2016$13,768,000
-21.3%
448,471
-23.6%
0.26%
-24.3%
Q2 2016$17,490,000
+319.8%
587,126
+1367.8%
0.35%
+79.5%
Q1 2014$4,166,00040,0000.20%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2016
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$20,706,0006.01%
Redmile Group, LLC 230,673$23,882,0002.95%
WEATHERBIE CAPITAL, LLC 241,419$24,994,0002.31%
Tekla Capital Management LLC 185,820$19,238,0002.02%
Ghost Tree Capital, LLC 25,000$2,588,0001.59%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$588,741,0001.56%
Iguana Healthcare Management, LLC 25,000$2,588,0001.48%
Eventide Asset Management 42,100$4,359,0001.34%
Bain Capital Public Equity Management, LLC 401,330$41,550,0001.17%
Rock Springs Capital Management LP 31,500$3,261,0001.16%
View complete list of PUMA BIOTECHNOLOGY INC shareholders